ClinConnect ClinConnect Logo
Search / Trial NCT06930456

Comparison Between Intravenous Hydrocortisone and Ondansetron in Prevention of Post Spinal Anesthesia Hypotension

Launched by NADA KAMEL ELGAMAL · Apr 9, 2025

Trial Information

Current as of July 01, 2025

Enrolling by invitation

Keywords

ClinConnect Summary

According to the medication investigated in this study, patients will be divided into three equal groups (40 each). Patients will receive one of the following 15 minutes before spinal anesthesia:

1. Hydrocortisone 100 mg (H group)
2. Ondansetron 8 mg (O group)
3. An identical volume of sterile distilled water (Control group) (C group).

Spinal anesthesia will be performed under complete aseptic conditions with the patient seated, a 25-gauge Quincke spinal needle is used to administer 3.5 ml of a 0.5% hyperbaric bupivacaine together with 25 micrograms of fentanyl at the L3-L4 or L4-L5 level...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • 1. ASA I and II (physical status according to American Society of Anesthesiologists).
  • 2. Patients aged 21 years or more.
  • 3. Either sex.
  • 4. Abdominal and lower limb operations.
  • Exclusion Criteria:
  • 1. Patient refusal.
  • 2. hemodynamic instability
  • 3. Hematological diseases, bleeding or coagulation abnormality.
  • 4. Local skin infection and sepsis at site of spinal anesthesia
  • 5. neuromuscular diseases (as myopathies, myasthenia gravies...)
  • 6. Preexisting neurological deficit or psychiatric diseases.
  • 7. Known intolerance to the study drugs.
  • 8. patients already receiving any of the study drugs.
  • 9. diabetic patient.

About Nada Kamel Elgamal

Nada Kamel Elgamal is a dedicated clinical trial sponsor committed to advancing medical research and enhancing patient outcomes through innovative therapeutic solutions. With a focus on rigorous scientific methodology and ethical standards, the organization oversees a diverse portfolio of clinical trials aimed at evaluating the safety and efficacy of new treatments across various therapeutic areas. By fostering collaboration among researchers, healthcare professionals, and regulatory bodies, Nada Kamel Elgamal strives to contribute to the global body of medical knowledge and improve healthcare practices.

Locations

Port Said, , Egypt

Patients applied

0 patients applied

Trial Officials

Magdy Ali Omera, prof. of Anesthesia and ICU

Study Chair

Port Said University, Faculty of Medicine, Department of Anesthesia

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported